What you need. When you need it. EV1000 Clinical Platform

Similar documents
61% SvO 2. Clarity. Simplified.

61% SvO 2. Clarity. Simplified.

Capture every aspect of hemodynamic status

86% P(iBP) Hypotension. Clarity

FloTrac Sensor and Edwards PreSep Central Venous Oximetry Catheter Case Presentations

Early detection. Proactive intervention.

Edwards FloTrac Sensor & Performance Assessments of the FloTrac Sensor and Vigileo Monitor

The Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the PreSep oximetry catheter for

The Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the Edwards PreSep oximetry catheter

Safe, simple and reliable closed blood sampling for effective patient blood management.9,14

Hemodynamic Optimization HOW TO IMPLEMENT?

The Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the PreSep oximetry catheter for

PulsioFlex Patient focused flexibility

Edwards Critical Care Education. Perioperative Goal-Directed Therapy Protocol Summary

An early warning indicator of tissue hypoxia.

Edwards Critical Care Education. Perioperative Goal-Directed Therapy Protocol Summary

Edwards Critical Care Education. Perioperative Goal-Directed Therapy Protocol Summary

Transpulmonary thermodilution in septic shock & ARDS

How can the PiCCO improve protocolized care?

What is. InSpectra StO 2?

Cogent 2-in-1 Hemodynamic Monitoring System

Making the Case For Less Invasive Flow Based Parameters: APCO + SVV. Patricia A. Meehan, RN, MS, CCRN (a) Education Consultant Edwards Lifesciences

Goal-directed vs Flow-guidedresponsive

Establishing the New Standard of Care for Inoperable Aortic Stenosis THE PARTNER TRIAL COHORT B RESULTS

The SAPIEN 3 TAVI Advantage

Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS

CARDIAC OUTPUT Monitoring ANDY CAMPBELL JOURNAL CLUB NOV 2011

The Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the PreSep oximetry catheter for

What is TAVR? Transcatheter Aortic Valve Replacement

Nurse Driven Fluid Optimization Using Dynamic Assessments

Edwards Lifesciences 2012 Investor Conference 12/4/2012

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Dr. F Javier Belda Dept. Anesthesiology and Critical Care Hospital Clinico Universitario Valencia (Spain) Pulsion MAB

Perioperative Goal- Protocol Summary

Perioperative Goal- Protocol Summary

Critical Care. Building Future Growth with Innovation. Katie M. Szyman Corporate Vice President, Critical Care

Cardiac Output Monitoring - 6

Hemodynamic Monitoring in Critically ill Patients in Arthur Simonnet, interne Tuteur : Pr. Raphaël Favory

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

2015 Facility and Physician Billing Guide Heart Valve Technologies

Sepsis Wave II Webinar Series. Sepsis Reassessment

Hemodynamic monitoring beyond cardiac output

Reducing Variation in Perioperative Fluid Utilization Results in Improved Surgical Outcomes

Full Disclosure. The case for why it matters. Goal-directed Fluid Resuscitation

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

Perioperative Goal Directed Therapy Improving the Quality of Care for Our Surgical Patients

Functional Hemodynamic Monitoring and Management A practical Approach

ThruPort Ergonic Minimal Incision Instrumentation

Obligatory joke. The case for why it matters. Sepsis: More is more. Goal-Directed Fluid Resuscitation 6/1/2013

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

Perioperative Fluid Management in ERPs

Hemodynamic Monitoring and Circulatory Assist Devices

PCV and PAOP Old habits die hard!

Standard Operating Procedure (SOP) Management of intervention group patients SOP 001

If you reduce variability in volume administration, HOW. you can reduce post-surgical complications, LOS and associated costs 1-4

The Use of Dynamic Parameters in Perioperative Fluid Management

What is TAVR? Transcatheter Aortic Valve Replacement

Early Goal-Directed Therapy

Sepsis Combine experience and Evidence. Eran Segal, MD Director General ICU, Sheba Medical Center, Israel

UTILITY of ScvO 2 and LACTATE

PiCCO based algorithms

towards early goal directed therapy

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Early-goal-directed therapy and protocolised treatment in septic shock

福島県立医科大学学術成果リポジトリ. Title laparoscopic adrenalectomy in patie pheochromocytoma. Midori; Iida, Hiroshi; Murakawa, Ma

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Edwards Critical Care Education

Assessing Preload Responsiveness Using Arterial Pressure Based Technologies. Patricia A. Meehan, RN, MS Education Consultant Edwards Lifesciences, LLC

Critical Care Product Catalogue

Clinical relevance of perioperative ScvO 2 monitoring

Presented by: Indah Dwi Pratiwi

EUROANESTHESIA 2008 Copenhagen, Denmark, 31 May - 3 June 2008 CENTRAL VENOUS OXYGEN SATURATION (SCVO 2 ): INTEREST AND LIMITATIONS

Fluid responsiveness Monitoring in Surgical and Critically Ill Patients

The cornerstone of treating patients with hypotension,

The Hemodynamic Puzzle

What is Aortic Stenosis?

Hemodynamic optimization of the OR patient. Wilbert Wesselink

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

haemodynamic monitoring

Fluid responsiveness and extravascular lung water

( 12 17mLO 2 /dl) 1.39 Hb S v O P v O2

3/14/2017. Disclosures. None. Outline. Fluid Management and Hemodynamic Assessment Paul Marik, MD, FCCP, FCCM

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART

Research Article Haemodynamic Monitoring in the Intensive Care Unit: Results from a Web-Based Swiss Survey

Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children?

Fluid bolus of 20% Albumin in post-cardiac surgical patient: a prospective observational study of effect duration

3/14/2017. Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care. Objectives. Developmental Response to Sepsis

Fluid management. Dr. Timothy Miller Assistant Professor of Anesthesiology Duke University Medical Center

Recent Less-invasive Circulatory Monitoring during Renal Transplantation

Sepsis Management: Past, Present, and Future

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

Goal directed fluid restriction during brain surgery: a prospective randomized controlled trial

SEPSIS: Seeing Through the. W. Graham Carlos MD, MSCR, ATSF, FACP

One monitor for the whole patient pathway

Global Myocardial Protection

Invasive Cardiac Output Monitoring and Pulse Contour Analysis. Harshad B. Ranchod Paediatric Intensivist Chris Hani Baragwanath Hospital COPICON 2011

Impedance Cardiography (ICG) Method, Technology and Validity

QUICK REFERENCE HEARTWARE HVAD PUMP FLOW INDEX

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Transcription:

What you need. When you need it. EV1000 Clinical Platform

EV1000 Clinical Platform The EV1000 clinical platform from Edwards Lifesciences presents the physiologic status of the patient in an intuitive and meaningful way. Designed in collaboration with you, the EV1000 clinical platform offers you scalability and adaptability for both the OR and ICU. The EV1000 clinical platform enables you to choose the parameters needed to monitor your patients and may be used with a variety of Edwards advanced hemodynamic monitoring tools for an integrated Edwards Critical Care System. EV1000 Clinical Platform + FloTrac ClearSight Finger Cuff Sensor PreSep Oximetry Catheter VolumeView Set = Edwards Critical Care System

CHOICE The EV1000 clinical platform provides the choice of the parameters you want to view and how you want to view them. The platform may be used with the Edwards advanced hemodynamic monitoring portfolio including the ClearSight finger cuff, FloTrac sensor, PreSep and PediaSat oximetry catheters and VolumeView set. The parameters provided by each are outlined below. Further, the platform provides a choice of screens so that you may view the parameters in a manner most meaningful to your clinical situation for visual clinical support. ClearSight Finger Cuff (Noninvasive) The ClearSight system extends clarity to more moderate and high-risk surgery patients and noninvasively provides continuous hemodynamic monitoring including SV, SVV, SVR, CO and continuous blood pressure. FloTrac Sensor (Minimally-Invasive) The FloTrac sensor easily connects to any existing arterial catheter and automatically calculates key flow parameters (CCO/CCI, SV/SVI, SVV, SVR/SVRI) every 20 seconds, making it the practical and reliable solution for hemodynamic optimization in moderate to high-risk surgery. PreSep Oximetry Catheter (Central Venous Catheter) The PreSep oximetry catheter continuously monitors central venous oxygen saturation (ScvO 2 ), which may be used in the Early Goal-Directed Therapy (EGDT) protocol 1 for the treatment of sepsis. VolumeView Set (Transpulmonary Thermodilution) The VolumeView set provides volumetric parameters (EVLW, GEDV, GEF, PVPI, ITBV) and continuous, calibrated hemodynamic parameters (CCO/CCI, SV/SVI, SVV, SVR/SVRI).

CLARITY CLINICAL SUPPORT CHOICE Visualized Physiology Hemodynamic Optimization Guiding Platform The EV1000 clinical platform presents patient hemodynamic information clearly and simply. Color-based indicators communicate patient status at a glance, and visual clinical support screens allow for immediate recognition and increased understanding of rapidly changing clinical situations for improved decision making. Monitoring and optimizing Stroke Volume (SV) by volume loading during the surgical procedure or in the immediate postoperative period is a key strategy for reducing postoperative complications.2,3 Stroke Volume Variation (SVV) measured can be used to tailor fluid therapy.2 Cardiac output measured continuously can be used (in combination with SaO2 and hemoglobin) to monitor and optimize DO2 with fluid (including red blood cells) and inotropic agents.4,5 The EV1000 clinical platform provides a choice of screen options to provide immediate insight to aid your therapeutic interventions. Presenting the physiologic status of the patient in an intuitive and meaningful way enables you to focus on your patient. Screen options include the real-time physiology screen (both intermittent and continuous), the cockpit screen, the goal positioning screen, graphical trend screens and the physio-relationship screen. Real-time Physiology Screen These advanced hemodynamic parameters, when combined with a Perioperative Goal-Directed Therapy (PGDT) protocol, are key to maintaining the patient in the optimal volume range.2 During surgery, as long as oxygen consumption is stable, ScvO2 can be used as a surrogate for DO2.6,7 An ScvO2 value >73% can be targeted using fluid (including red blood cells) and inotropic agents.8 The animated physiology screen visually depicts the dynamic changes occurring in your patient. By delivering parameters visually as well as numerically, the EV1000 clinical platform allows you to more easily determine the root cause of a particular situation, further assisting and guiding your clinical decisions. Graphical Trend Screen Physio-relationship Screen The graphical trend screen allows you to select, place, and track interventions over time while providing key parameter trending data. The percent change indicator provides additional insight into the patient's condition. The physio-relationship screen depicts the balance between oxygen delivery and consumption, allowing you to identify the root cause of the imbalance and the most appropriate intervention. Graphical Trend Screen Select Intervention Continuous Physio-relationship Screen Hypovolemia Graphical Trend Screen View Intervention Detail Intermittent Physio-relationship Screen Pulmonary Edema Perioperative Goal-Directed Therapy Screens Heartbeat reflects current heart rate Heart size reflects patient volumetric status Vasculature can depict vasoconstriction or vasodilation Flow of blood cells represents cardiac output 5 levels of lung water shown in lungs Replicated patient position on Frank-Starling curve Continuous Physiology Screen The EV1000 clinical platform provides tools for performing Perioperative Goal-Directed Therapy, enabling a user to track and manage key parameters in the optimal range. With enhanced parameter tracking, clinicians have the ability to create and monitor customized protocols. The Time In Target Value value represents the accumulated percentage of time a parameter has been within target during an active tracking session. Clinicians have the ability to track known protocol targets in addition to identifying the optimal Stroke Volume (SV) target during active monitoring sessions. Intermittent Physiology Screen Perioperative Goal-Directed Therapy Screen Stroke Volume Optimization Perioperative Goal-Directed Therapy Screen Cardiac Index and Stroke Volume Variation

CONNECTIVITY Connecting to Your Hospital Information System Connectivity within the EV1000 clinical platform enables you to optimize your clinical workflow. Edwards provides options for connecting the platform within the clinical environment that include IFMout through a serial connection and HL7 through an Ethernet port. HL7 is a standard for exchanging information between medical applications. PGDT Analytics This tool enables clinicians to access EV1000 clinical platform monitoring data in an offline PC application. The software creates monitoring dashboards for parameter, cohort and cross cohort analytics. It also provides time in target values from Perioperative Goal-Directed Therapy sessions. Single Cohort PGDT Analytics Helping to advance the care of the acutely ill for 40 years, Edwards Lifesciences seeks to provide the valuable information you need, the moment you need it. Through continuing collaboration with you, ongoing education and our never-ending quest for advancement, our goal is to deliver clarity in every moment. Visit Edwards.com/EU/EV1000 to learn more 1. Rivers E, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368 1377. 2. Bellamy MC. Wet, dry or something else? Br J Anaesth 2006;97(6):755-757. 3. Michard & Biais. Rational fluid management: dissecting facts from fiction. Br J Anaesth 2012. 4. Boyd O, et al. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA. 1993;270(22):2699-2707. 5. Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ. 1999;318:1099 103. 6. Rady MY. Resuscitation of the Critically Ill in the ED: Responses of Blood Pressure, Heart Rate, Shock Index, Central Venous Oxygen Saturation, and Lactate. Am J Emerg Med 1996, 218-225. 7. Pinsky MR. Hemodynamic monitoring in the intensive care unit. Clin Chest Med 2003, 549-560. 8. Donati A, Loggi S, Preiser J-C, et al. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007;132:1817-1824. For professional use. CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events. Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity. Edwards, Edwards Lifesciences, the stylized E logo, Edwards Critical Care System, Clarity in Every Moment, ClearSight, EV1000, FloTrac, PediaSat, PreSep, and VolumeView are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners. 2016 Edwards Lifesciences Corporation. All rights reserved. E6010/02-16/CC Edwards Lifesciences edwards.com One Edwards Way Irvine, California 92614 USA Switzerland Japan China Brazil Australia India